News for Evolent Health, Inc. (EVH)

Summary Evolent Health Inc (EVH), a company dedicated to improving health outcomes for individuals with complex conditions, announced on July 14, 2025, that it

PR NewswireWASHINGTON, July 14, 2025 Company to Participate in Upcoming ConferencesWASHINGTON, July 14, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EV

On June 30, 2025, Wellington Management Group LLP executed a substantial reduction in its holdings of Evolent Health Inc. The firm decreased its position by 9,7

Shares of Evolent Health Inc (EVH) fell 3.90% in mid-day trading on Jul 9. The stock reached an intraday low of $11.24, before recovering slightly to $11.32,

Summary Evolent Health Inc (EVH), a company dedicated to improving health outcomes for individuals with complex conditions, announced on July 9, 2025, the appoi

Evolent Health (EVH) has announced significant enhancements to its leadership team, aimed at bolstering its clinical and financial divisions. Dr. David Lim, wit

Evolent Health, Inc. (NYSE:EVH) is one of the top 10 healthcare AI stocks to buy according to hedge funds. JMP Securities reaffirmed its Market Outperform rating and $13.00 price target on Evolent Health, Inc. (NYSE:EVH), highlighting a more stable and promising outlook for the company. The firm described Evolent’s current risk/reward profile as “favorably skewed,” […]

Evolent Health (EVH) recently shared a series of encouraging updates via a press release, which have been described as "incrementally positive" by UBS. The comp

Evolent Health, Inc. (EVH) has received a reaffirmed analyst rating from JMP Securities as of June 20, 2025. The rating remains at "Market Outperform," indicati

Summary On June 20, 2025, Evolent Health Inc (EVH), a company dedicated to improving health outcomes for individuals with complex conditions, announced its cont

PR NewswireWASHINGTON, June 20, 2025 Notes accelerating 2026 revenue bookings forecastSecures incremental non-dilutive financingWASHINGTON, June 20, 2025 /

Evolent Health (EVH) reaffirms its Q2 and full-year 2025 Adjusted EBITDA guidance, expecting robust performance. Secures a Commitment Letter with Ares M

Evolent Health, Inc. (NYSE:EVH) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ETCompany ParticipantsSeth Blackley - Chief Executive OfficerJohn...

Although the revenue and EPS for Evolent Health (EVH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The following slide deck was published by Evolent Health, Inc.

UBS analyst Kevin Caliendo has increased the price target for Evolent Health (EVH) shares from $14 to $15, maintaining a Buy rating. According to Caliendo, Evol

Q1 Revenue: $483.6 million, impacted by contractual changes and true-ups.Adjusted EBITDA Impact: Favorable net impact of $0.4 million from prior year developme

May 08, 2025 / 09:00PM GMTOperator Welcome to the Evolent Health conference call for the first quarter ended March 31, 2025. As a reminder, this conference call

Evolent Health (EVH) has reported a first-quarter revenue of $483.65 million, exceeding the anticipated $460.28 million. The company's CEO, Seth Blackley, expre